Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

Journal of Virology

Volumn 73, Issue 11, 1999, Pages 9063-9071

  Dupuy, Catherine ^a   Buzoni Gatel, Dominique ^b   Touzé, Antoine ^a   Bout, Daniel ^b   Coursaget, Pierre ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CANCER RISK; CYTOTOXIC T LYMPHOCYTE; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UTERINE CERVIX CANCER; VIRUS PARTICLE; WART VIRUS;

EID: 0032875712     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.11.9063-9071.1999     Document Type: Article

References (62)

1. Balmelli, C., R. Roden, A. Potts, J. Schiller, P. De Grandi, and D. Nardelli-Haefliger. 1998. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions. J. Virol. 72:8220-8229.
2. Ban, E. M., F. W. Van Gimkel, J. W. Simecka, H. Kiyona, H. L. Robinson, and J. R. McGhee. 1997. Mucosal immunization with DNA encoding influenza hemagglutinin. Vaccine 15:811-813.
3. Bergquist, C., E.-L. Johanson, T. Lagergard, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
4. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, H. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
5. Bourguin, I., T. Chantes, M.-N. Mevelec, J. P. Woodman, and D. Bout. 1991. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin. FEMS Microbiol. Lett. 81:265-272.
6. Breitburd, F., R. Kirnbauer, N. L. Hubbert, B. Nonnenlacher, C. Trin-Dinh-Desmarquet, G. Orth, J. T. Schiller, and D. R. Lowy. 1995. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69:3959-3963.
7. Campion, M. J. 1987. Clinical manifestations and natural history of genital papillomavirus infections. Obstet. Gynecol. Clin. North Am. 14:363-388.
8. Chan, S.-H., H.-U. Bernard, M. Ratterree, T. A. Birkebak, A. J. Faras, and R. Ostrow. 1997. Genomic diversity and evolution of papillomaviruses in rhesus monkeys. J. Virol. 71:4938-4943.
9. Christensen, N. D., R. Kirnbauer, J. T. Schiller, S. J. Ghim, R. Schlegel, A. B. Jenson, and J. W. Kreider. 1994. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 205:329-335.
10. Debard, N., D. Buzoni-Gatel, and D. Bout. 1996. Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection. Infect. Immun. 64:2158-2166.
11. De Bruijn, M. L. H., H. L. Greenstone, H. Vermeulen, C. J. M. Melief, D. R. Lowy, J. T. Schiller, and W. M. Kast. 1998. L1-specific protection from tumour challenge elicited by HPV 16 virus-like particles. Virology 250:371-376.
12. Di Tommaso, A., G. Saletti, M. Pizza, R. Rappuoli, G. Dougan, S. Abrignani, G. Douce, and M. T. De Magistris. 1996. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxin mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect. Immun. 64:974-979.
13. Donnelly, J., J., D. Martinez, K. U. Jansen, R. W, Ellis, D. L. Montgomery, and M. A. Liu, 1995. Protection against papillomavirus with a polynucleotide vaccine. J. Infect. Dis. 713:314-320.
14. Dupuy, C., D. Buzoni-Gatel, A. Touzé, P. Le Cann, D. Bout, and P. Coursaget. 1997. Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles. Microb. Pathog. 22:219-225.
15. Fidel, P. L., N. A. Wolf, and M. A. Kukuruga. 1996. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun. 64:3793-3799.
16. Gallichan, W. S., and K. L. Rasenthal. 1995. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589-1595.
17. Hagensee, M. E., J. J. Carter, G. C. Wipf, and D. A. Galloway. 1995. Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology 204:174-182.
18. Hazama, M., A. Mayumi-Aono, T. Miyazaki, S. Hinuma, and Y. Fujisawa. 1993. Intranasal immunization against herpes simplex virus infection by using a recombinant glycoprotein D fused with immunomodulating proteins, the B subunit of Escherichia coli heat-labile enterotoxin and interleukin-2. Immunology 78:643-649.
19. Hurwitz, J. L., F. S. Kenneth, M. Y. Sangster, A. Portner, R. E. Sealy, D. H. Dawson, and C. Coleclough. 1997. Intranasal Sendai virus vaccine protects African green monkeys from infection with human parainfluenza virus-type one. Vaccine 15:533-540.
20. Kawanishi, H., L. Saltzman, and W. Strober. 1983. Mechanisms regulating IgA class-specific immunoglobulin production in murine gut-associated lymphoid tissues. I. T cells derived from Peyer's patches that switch sIgM B cells to sIgA B cells in vitro. J. Exp. Med. 157:433-450.
21. King, N. J., E. L. Parr, and M. B. Parr. 1998. Migration of lymphoid cells from vaginal epithelium to iliac lymph nodes in relation to vaginal infection by herpes simplex virus type 2. J. Immunol. 160:1173-1180.
22. Kirnbauer, R., F. Booy, N. Cheng, and D. R. Lowy. 1992. Papillomavirus L1 major capsid protein self assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. USA 89:12180-12184.
23. Klavinskis, L. S., L. A. Bergmeier, L. Gao, E. Mitchell, R. Ward, G. Layton, R. Brookes, N. J. Meyers, and T. Lehner. 1996. Mucosal or targeted lymph node immunization of macaques with a particulate SIVp27 protein elicits virus-specific CTL in the genito-rectal mucosa and draining lymph nodes. J. Immunol. 157:2521-2527.
24. Klavinskis, L. S., C. Barnfield, L. Gao, and S. Parker. 1999. Intranasal immunization with plasmid DNA-lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J. Immunol. 162:254-262.
25. Kuklin, N., M. Daheshia, K. Karem, E. Manickan, and B. T. Rouse. 1997. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization. J. Virol. 71:3138-3145.
26. Kuper, C. F., P. J. Koornstra, M. H. Hameleers, B. J. Biewenga, A. M. Split, P. J. C. Duijvestijn, P. Van Breda Vriesman, and T. Sminia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219-224.
27. Kutteh, W. H., and J. Mesteskey. 1994. Secretory immunity in the female reproductive tract. Am. J. Reprod. Immunol. 31:40-45.
28. Le Cann, P., P. Coursaget, S. Iochman, and A. Touzé. 1994. Self-assembly of human papillomavirus type 16 capsids by expression of the L1 protein in insect cells. FEMS Microbiol. Lett. 117:269-274.
29. Lehner, T., L. A. Bergmeier, C. Panagiotidi, L. Tao, R. Brookes, L. S. Klavinskis, J. Walker, R. G. Ward, L. Hussain, A. J. H. Gearing, and S. E. Adams. 1992. Induction of mucosal and systemic immunity to a recombinant simian immunodeficiency viral protein. Science 258:1365-1369.
30. Liu, X. S., I. Abdul-Jabbar, Y. Mei Qi, I. H. Frazer and J. Zhou. 1999. Mucosal immunization with papillomavirus virus-like particles elicits systemic and mueosal immunity. Virology 252:39-45.
31. Livingston, J. B., S. Lu, H. Robinson, and D. J. Anderson. 1998. Immunization of the female genital tract with a DNA-based vaccine. Infect. Immun. 66:322-329.
32. Lohman, B. L., C. J. Miller, and M. B. McChesney. 1995. Antiviral cytotoxic T lymphocytes in vaginal mucosa of simian immunodeficiency virus-infected rhesus macaques. J. Immunol. 155:5855-5860.
33. Lowe, R. S., D. R. Brown, J. T. Bryan, J. C. Cook, H. A. George, K. J. Hofmann, W. M. Hurni, J. G. Joyce, E. D. Lehman, H. Z. Markus, M. P. Neeper, L. D. Shultz, A. R. Shaw, and K. U. Jansen. 1997. Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-virus-like particles expressed in yeast. J. Infect. Dis. 176:1141-1145.
34. Marx, P. A., R. W. Compans, A. Gettie, J. K. Staas, R. M. Gilley, M. J. Mulligan, G. V. Yamschikov, D. Chen, and J. H. Eldridge. 1993. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 260:1323-1327.
35. McDermott, M. R., L. J. Brais, and M. J. Evelegh. 1990. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2. J. Gen. Virol. 71:1497-1504.
36. Menge, A. C., S. M. Michalek, M. W. Russell, and J. Mestecky. 1993. Immune response of the female genital tract after oral and local immunization with keyhole limpet hemocyanin conjugated to the cholera toxin B subunit. Infect. Immun. 61:2162-2171.
37. Mestecky, J. 1987. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J. Clin. Immunol. 7:265-276.
38. Mitchell, E. A., L. A. Bergmeier, C. Doyle, R Brookes, Y. Wang, and T. Lehner. 1998. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur. J. Immunol. 28: 3066-3072.
39. Muñoz, N., F. X. Bosch, S. De Sanjosé, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzales, J. M. Kaldot, E. Guerreoro, A. Lorincz, M. Santamaria, P. Alonzo de Ruiz, N. Arisizabal, and K. Shah. 1992. The causal link between human papillomavirus and invasive cervical cancer, a population-based case-control study in Colombia and Spain. Int. J. Cancer 52:743-749.
40. Muster, T., B. Ferko, A. Klima, M. Purtscher, A. Trkola, P. Schulz, A. Grassauer, O. G. Engelhardt, A. Garcia-Sastre, P. Palese, and H. Katinger. 1995. Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus. J. Virol. 69:6678-6686.
41. Nardelly-Haefliger, D., R. B. S. Roden, J. Benyacoub, R. Sahli, J.-P. Kraehenbuhl, J. T. Schiller, P. Lachat, A. Potts, and P. De Grandi. 1997. Human papillomavirus type 16 virus-like particles expressed in attenuated Salmonella typhimurium elicit mucosal and systemic neutralizing antibodies in mice. Infect. Immun. 65:3328-3336.
42. O'Neal, C. M, S. E. Crawford, M. K. Estes, and M. E. Conner. 1997. Rotavirus virus-like particles administered mucosally induce protective immunity. J. Virol. 71:8707-8717.
43. Pardoll, D. M., and A. M. Beckering. 1995. Exposing the immunology of naked DNA vaccines. Immunity 3:165-169.
44. Parr, M. B., and E. L. Parr. 1994. Mucosal immunity in the female and male reproductive tract, p. 677-689. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. R. McGhee, and J. Bienenstock (ed.), Handbook of mucosal immunology. Academic Press, Inc., San Diego, Calif.
45. Parr, M. B., and E. L. Parr. 1998. Mucosal immunity to herpes simplex virus type 2 in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:2677-2685.
46. Perry, L. L., K. Feilzer, J. L. Portis, and H. D. Caldwell. 1998. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J. Immunol. 160:2905-2914.
47. Peterson, E. M., J. Z. You, V. Motin, and L. M. de la Maza. 1999. Intranasal immunization with Chlamydia trachomatis, serovar E, protects from a subsequent vaginal challenge with the homologous serovar. Vaccine 17:2901-2907.
48. Pisani, P., D. M. Parkin, N. Munoz, and J. Ferlay. 1997. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol. Biomarkers Prev. 6:387-400.
49. Ramsay, A. J. 1995. Genetic approaches to the study of cytokine regulation of mucosal immunity. Immunol. Cell. Biol. 73:484-488.
50. Sasaki, S., K. Hamajima, J. Fukushima, A. Ahata, N. Ishii, I. Gorai, F. Hirahara, H. Mohri, and K. Okuda. 1998. Comparison of intranasal and intramuscular immunization against human immunodeficiency virus type 1 with a DNA-monophosphoryl lipid A adjuvant. Infect. Immun. 66:823-826.
51. Schiller, J. T., and R. B. S. Roden. 1995. Papillomavirus-like particles. Papillomavirus Rep. 6:121-128.
52. Staats, H. F., W. G. Nichols, and T. J. Palkers. 1996. Mucosal immunity to HIV 1 : systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A). J. Immunol. 157:462-472.
53. Suxich, J. A., S. J. Ghim, F. J. Palmer-Hill, W. T. White, J. K. Tamura, J. A, Bell, J. A. Newsome, A. B. Jenson, and R. S. Schlegel. 1995. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA 92:11553-11557.
54. Syrjanen, K. J. 1987. Biology of human papillomavirus infections and their role in squamous cell carcinogenesis. Med. Biol. 65:21-39.
55. Tamura, S. I., Y. Samegai, H. Kurata, T. Nagamine, C. Aizawa, and T. Kurata. 1988. Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit. Vaccine 6:409-413.
56. Touzé, A., C. Dupuy, M. Chabaud, P. Le Cann, and P. Coursaget. 1995. Production of human papillomavirus type 45 virus-like particles in insect cells using recombinant baculovirus. FEMS Microbiol. Lett. 141:111-116.
57. Touzé, A., S. El Mehdaoui, P. Y. Sizaret, C. Mougin, N. Munoz, and P. Coursaget. 1998. The L1 major capsid protein of human papillomavirus type 16 variants affects yield of virus-like particles produced in an insect cell expression system. J. Clin. Microbiol. 36:2046-2051.
58. Touzé, A., N. Enogat, Y. Buisson, and P. Coursaget. 1999. Baculovirus expression of chimeric hepatitis B core particles with hepatitis E epitopes and their use in a hepatitis E immunoassay. J. Clin. Microbiol. 37:438-441.
59. Ulmer, J. B., J. J. Donnelly, S. E. Parker, G. H. Rhodes, P. L. Felgner, and V. J. Dwarki. 1993. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749.
60. VanCott, T. C., R. W. Kaminski, J. R. Mascola, V. S. Kalyanaraman, N. M. Wassef, C. R. Alving, J. T. Ulrich, G. H. Lowell, and D. L. Birx. 1998. HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp 160. J. Immunol. 160:2000-2012.
61. Wang, B., K. Dang, M. G. Agadjannyan, V. Srikantan, F. Li, K. E. Uen, J. Boyer, M. Merva, W. V. Williams, and D. B. Weiner. 1997. Mucosal immunization with a DNA vaccine induces immune responses against HIV-1 at a mucosal site. Vaccine 15:821-825.
62. Wu, H. Y., and M. W. Russell. 1993. Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit. Infect. Immun. 61:314-322.